HPV Vaccination Uptake Among Vaccine-Eligible U.S. Adults with and Without a Cancer History: A National Health and Nutrition Examination Survey Analysis, 2011-2023.
- 1College of Pharmacy and Pharmaceutical Sciences, Institute of Public Health, Florida A&M University, Tallahassee, FL 32307, USA.
Abstract
Background
Human papillomavirus includes more than 200 types, classified by cancer risk. Since 2006, the vaccine has effectively prevented human papillomavirus infection and associated cancers; however, coverage among adults remains low. Furthermore, research examining human papillomavirus vaccination among adults with a cancer history is limited.Objective
To estimate vaccination uptake for human papillomavirus among U.S. adults aged 20-47 and compare uptake by cancer history.Methods
This study used data from the National Health and Nutrition Examination Survey from 2011 to 2023. The final analytic sample included 13,511 adults aged 20-47 with self-reported vaccination status and cancer history. The data were weighted to account for the complex survey design and produce nationally representative estimates.Results
Among eligible adults, 84.7% were unvaccinated, 2.9% were under-vaccinated, and 12.4% had completed the vaccine series. Among eligible adults with a self-reported cancer history, the majority were unvaccinated. Vaccination completion differed by sociodemographic and healthcare-related factors.Conclusions
Human papillomavirus vaccination remained low among eligible U.S. adults, including those with a self-reported cancer history. These findings support efforts to improve adult vaccination coverage and prevent human papillomavirus infections and associated cancers.
Related
- Estimation of Antimicrobial-Resistant Mycoplasma genitalium Infections in People Aged 14–59 Years: Results From the National Health and Nutrition Examination Survey, United States, 2017–2018
- Association Between Aerobic Physical Activity and Hypertension Among U.S. Adults: A Cross-Sectional Analysis of NHANES (National Health and Nutrition Examination Survey) 2021-2023
- Association Between Sleep Duration and Obesity Phenotypes in Apparently Healthy Korean Adults: A Cross-Sectional Study Using the Korea National Health and Nutrition Examination Survey 2013–2015
- Differences in health risk behavior clusters by occupational group among Korean adult workers: a sex-stratified latent class analysis using the Korea National Health and Nutrition Examination Survey (KNHANES) 2022–2024
- Association of breakfast skipping with diet-quality-based low-carbohydrate and low-fat diet scores and metabolic syndrome components among Korean young adults: Korea National Health and Nutrition Examination Survey 2021–2023
BibTeX
@article{saintibert2026vaccination,
title = {{HPV Vaccination Uptake Among Vaccine-Eligible U.S. Adults with and Without a Cancer History: A National Health and Nutrition Examination Survey Analysis, 2011-2023.}},
author = {Jessica Saintibert and Tammie M Johnson},
journal = {Vaccines},
year = {2026},
month = oct,
doi = {10.3390/vaccines14100892},
url = {https://europepmc.org/article/MED/42931421},
note = {CC BY},
}
RIS
TY - JOUR
TI - HPV Vaccination Uptake Among Vaccine-Eligible U.S. Adults with and Without a Cancer History: A National Health and Nutrition Examination Survey Analysis, 2011-2023.
AU - Jessica Saintibert
AU - Tammie M Johnson
PY - 2026
DA - 2026/10/12
JO - Vaccines
DO - 10.3390/vaccines14100892
UR - https://europepmc.org/article/MED/42931421
AB - Background Human papillomavirus includes more than 200 types, classified by cancer risk. Since 2006, the vaccine has effectively prevented human papillomavirus infection and associated cancers; however, coverage among adults remains low. Furthermore, research examining human papillomavirus vaccination among adults with a cancer history is limited.Objective To estimate vaccination uptake for human papillomavirus among U.S. adults aged 20-47 and compare uptake by cancer history.Methods This study used data from the National Health and Nutrition Examination Survey from 2011 to 2023. The final analytic sample included 13,511 adults aged 20-47 with self-reported vaccination status and cancer history. The data were weighted to account for the complex survey design and produce nationally representative estimates.Results Among eligible adults, 84.7% were unvaccinated, 2.9% were under-vaccinated, and 12.4% had completed the vaccine series. Among eligible adults with a self-reported cancer history, the majority were unvaccinated. Vaccination completion differed by sociodemographic and healthcare-related factors.Conclusions Human papillomavirus vaccination remained low among eligible U.S. adults, including those with a self-reported cancer history. These findings support efforts to improve adult vaccination coverage and prevent human papillomavirus infections and associated cancers.
SN - 2076-393X
ER -